Back
Innovator IBD Breakout Opportunities ETF 10K Form
Buy
59
BOUT
Innovator IBD Breakout Opportunities ETF
Last Price:
$40.29
Seasonality Move:
1.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BOUT News And Ratings
See the #1 stock for the next 7 days that we like better than BOUT
BOUT Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Innovator IBD Breakout Opportunities ETF Earnings Forecast
Key Innovator IBD Breakout Opportunities ETF Financial Ratios
Innovator IBD Breakout Opportunities ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | BOUT |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BOUT Technical Analysis vs Fundamental Analysis
Buy
59
Innovator IBD Breakout Opportunities ETF (BOUT)
is a Buy
Is Innovator IBD Breakout Opportunities ETF a Buy or a Sell?
-
Innovator IBD Breakout Opportunities ETF stock is rated a BuyThe current Innovator IBD Breakout Opportunities ETF [BOUT] share price is $39.85. The Score for BOUT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.